Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MERIDIAN BIOSCIENCE INC | Executive VP-Diagnostics | Common Stock | 0 | $20.38 | Jan 31, 2023 | Direct | |
MERIDIAN BIOSCIENCE INC | Executive VP-Diagnostics | Stock Option (Right to Buy) | 0 | $13.25 | Jan 31, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
VIVO | MERIDIAN BIOSCIENCE INC | Jan 31, 2023 | 6 | -$666K | 4 | Jan 31, 2023 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Nov 15, 2022 | 1 | -$117K | 4 | Nov 17, 2022 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Nov 4, 2022 | 1 | -$25.2K | 4 | Nov 8, 2022 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Sep 16, 2022 | 1 | -$11.5K | 4 | Oct 5, 2022 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Nov 15, 2021 | 1 | -$45K | 4 | Dec 16, 2021 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Nov 15, 2021 | 2 | $0 | 4 | Nov 16, 2021 | Executive VP-Diagnostics |
VIVO | MERIDIAN BIOSCIENCE INC | Nov 4, 2021 | 2 | $0 | 4 | Nov 8, 2021 | Executive VP-Diagnostics |